A total daily insulin dose of about 0.2 U/kg was optimal to cover the fast day, "although there is considerable variability between patients."…

A peptide called caerulein converted existing cells in the pancreas into insulin-generating beta cells….

Adequate glycemic control is 48% and health insurance coverage among Latino diabetics is 52.4%…. 

  Rudy Bilous MD, FRCP Richard Donnelly MD, PHD, FRCP, FRACP   The most common cause of type 1 diabetes (over 90% of cases) is T cell-mediated autoimmune destruction of the islet beta cells leading to a failure of insulin production. The exact aetiology is complex and still imperfectly understood. However, it …

  In this week’s Homerun Slides, we begin a series which Dr. Stanley Schwartz presented at the 2014 ADA Scientific Sessions, where he outlined some of the problems with the current diabetes classification system. This first section discusses the definition of LADA and shows how diabetes diagnosis characteristics frequently overlap….

Diabetes is a huge and growing problem, and the costs to society are high and escalating. In South and Central America, the number of people with diabetes will increase by 60% by 2035. The Top 5 countries for prevalence are: Puerto Rico, Nicaragua, Dominican Republic, Guatemala, and El Salvador. To …

SUDOSCAN: Early Identification of Peripheral Autonomic Neuropathies  SUDOSCAN+ is a test that provides an accurate evaluation of sweat gland function focusing on small nerve fibers within the peripheral nervous system innervating the sweat glands. SUDOSCAN+ measures the ability of the sweat glands to release chloride ions in response to an …

Diabetes Drug Empagliflozin (Jardiance- SGLT-2) Wins FDA Approval. More news in next week’s issue. GSK’s Tanzeum (GLP-1 agonist) is now available in pharmacies in the U.S.

Women who ate 5 grams daily of green-plant membranes purified from spinach lost more weight and had fewer urges to eat unhealthy foods than did those given a placebo, Swedish researchers reported. Women who consumed green-plant membranes also had higher secretions of the satiety hormone GLP-1. Green-plant membranes slow fat …

Xultophy, a type 2 diabetes candidate, received a positive opinion from the European Medicines Agency’s Committee. Xultophy is a once-daily single injection combination of insulin degludec and liraglutide. The CHMP recommended the approval of Xultophy for the treatment of adults suffering from type 2 diabetes in combination with glucose-lowering oral …